Printer Friendly
The Free Library
14,632,679 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

invivodata Announces the Industry's First Truly Global Electronic Patient Diary Solution; Exclusive Wireless Cradle Simplifies Data Uploads Across Global Clinical Trials.


PITTSBURGH -- invivodata(R) inc., the industry leader in electronic patient reported outcomes (ePRO) solutions for global clinical research, today announced an exclusive agreement with Enfora L.P., a leading provider of wireless voice and data devices. This agreement allows invivodata to incorporate Enfora's custom wireless modem A modem and antenna that transmits and receives over the air. Wireless modems support several technologies, including 802.11, Bluetooth, CDPD, DataTAC, Mobitex and Ricochet. There are wireless modems for laptops, handhelds and cellphones.  cradle into DiaryPRO(TM), its electronic patient diary A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken.  (eDiary) system, to deliver a truly global ePRO solution to its pharmaceutical, biotechnology and medical device clients.

Using Enfora's wireless modem cradle, invivodata supplies trial sponsors with a single eDiary device that can reliably upload See download.

upload - /uhp'lohd/ To transfer programs or data over a digital communications link from a smaller or peripheral "client" system to a larger or central "host" one.

Opposite: download.
 patient data regardless of the country in which it is being used or the type of phone connection the patient has at home. Although eDiaries that use a land-based modem cradle are typically less expensive and generally preferred, data uploads from those devices rely on analog phone The original telephone technology, which converts air vibrations into an analogous electrical frequency. Unless a key telephone system, digital PBX or voice over IP (VoIP) is used, most homes and small offices still use analog phones, and the local loop is mostly analog.  lines, which are uncommon in some parts of the world. As a result, until now, trial sponsors have had to use a combination of wired and wireless eDiaries in their global clinical trials, increasing complexity in development, training and implementation.

The invivodata solution overcomes several common challenges encountered when implementing both wired and wireless diaries in a single clinical trial. Due to differences in screen size and usability How easy something is to use. Both software and Web sites can be tested for usability. Considering how difficult applications are to use and Web sites are to navigate, one would wish that more designers took this seriously. See user interface and usability lab.  between wired and wireless handheld devices, sponsors have tended to incur significant additional costs, time delays and data risks when providing different devices to patients participating in the same trial. With invivodata's global solution, a single eDiary device now meets a need that otherwise requires two different devices.

"By essentially giving wireless capabilities to wired hand-held devices, we're delivering a solution that allows sponsors to run more efficient ePRO trials across multiple countries with just one type of device, thereby simplifying the process for our clients," said Doug Engfer, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of invivodata. "We are pleased to add this truly global solution to our portfolio of innovative products that help clinical trial sponsors capture the most valid and reliable PRO data."

"We worked closely with invivodata to develop this wireless cradle for use in clinical trials," said Mark Weinzierl, president and CEO of Enfora. "Our experience in wireless technology solutions combined with invivodata's ePRO-based trial expertise resulted in a unique solution that will contribute to better clinical research."

About invivodata inc.

invivodata (www.invivodata.com) combines behavioral science behavioral science
n.
A scientific discipline, such as sociology, anthropology, or psychology, in which the actions and reactions of humans and animals are studied through observational and experimental methods.
, information technology and clinical expertise to capture the highest-quality electronic Patient Reported Outcome (ePRO) data in clinical research. The invivodata solution, which includes DiaryPRO for real-time PRO data collection and SitePRO(TM) for site-based PRO data collection, is based on patented compliance methods which include a proven patient management system that gives researchers and sponsors visibility into study progress and improves trial efficiencies. Strengthened by its regulatory and scientific expertise, invivodata is the industry-leading eDiary provider for delivering primary efficacy data for FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approvals. Its solutions have been used in 140 clinical trials worldwide by more than 55,000 patients, collecting over 89 million patient-initiated entries for studies in over 65 disease states. invivodata's scalable business model enables it to satisfy diverse client needs and meet the increasing global demand for its innovative solutions. invivodata inc. is a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA.

About Enfora

Based in Plano, Texas Plano (IPA: /ˈpleɪnoʊ/) is a wealthy suburb of Dallas, Texas, located to the north, mainly within Collin County, but also extending into Denton County. According to the 2000 U.S. , Enfora L.P. is a provider of wireless communications wireless communications

System using radio-frequency, infrared, microwave, or other types of electromagnetic or acoustic waves in place of wires, cables, or fibre optics to transmit signals or data.
 solutions for the growing number of integrators and mobile workers. Enfora's products are designed to provide access to mission-critical data, files, and applications via a Wi-Fi or GSM/GPRS connection--quickly and wirelessly. For more information, view Enfora on the World Wide Web at www.enfora.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company Profile
Date:Mar 6, 2006
Words:610
Previous Article:AMCC Leverages SONET/SDH Design Expertise to Deliver State-of-the-Art PHY Solutions for Wide Customer Base; Quad-Channel CDR and Quad-Channel...
Next Article:Objectivity Becomes Gold Member of the National Visualization and Analytics Center; Joins Industrial Membership of the National Visualization and...
Topics:



Related Articles
Advanced Bionics to Use invivodata's Electronic Diary in Migraine Trial; Pain Trial Experience is Critical Factor in eDiary Decision.
Rinat Neuroscience Selects invivodata's Electronic Patient Diary System for Use in Osteoarthritis Study.(Company Profile)
invivodata Announces First Integration of Devices in a Clinical Trial; Clinical Trial Sponsor Benefiting From More Reliable Data for Evaluating...
Clinical-Trials Company Improves Reliability and Reduces Trial Costs Using Handhelds to Capture Patient Data Wirelessly.
invivodata Expands Its Wireless Global Solution Offering; Innovative Tool Gives Trial Sponsors Options for Reliable Data Uploads.(Company overview)
invivodata Partners with Orange to Ensure Secure, Reliable Wireless Data Transmissions from eDiaries in Clinical Trials.(Company overview)
MediQuest Therapeutics Selects invivodata's DiaryPRO for Use in Second Phase III Trial for Raynaud's Phenomenon.
invivodata Completes Strategic Initiatives, Expands ePRO Solutions for Global Clinical Trials.
invivodata and Medidata Solutions Announce Integration of DiaryPRO and Medidata Rave; Nabi Biopharmaceuticals Deploys Integrated Solution to Increase...
invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial Execution.(Company...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles